A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2015 |
| Author/s |
author: Martin S. Tallman Clive S Zent Timothy G. Call Selina Luger Mark R Litzow Hillard M. Lazarus |
| Publication date | December 10, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |